Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Principia Biopharma, A Sanofi Company

Clinical trials sponsored by Principia Biopharma, A Sanofi Company, explained in plain language.

Now part of Sanofi S.A. SNY NASDAQ

A biopharmaceutical company, now a subsidiary of Sanofi, focused on developing treatments for autoimmune diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 4

New pill could help people with low platelet disorder

Disease control Ongoing

This phase 3 trial tests an oral drug called rilzabrutinib in 232 adults and adolescents with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Participants receive either rilzabrutinib or a placebo…

Phase: PHASE3 • Sponsor: Principia Biopharma, a Sanofi Company • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC